J&J's $40B split-off sets stage for pharma, medical tech expansion

By The Wall Street Journal
| September 05, 2023

The healthcare giant's separation of its consumer-health business arms it with billions in cash for allocating capital in the remaining businesses.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...